Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
Semih Başçı, Naim Ata, Fevzi Altuntaş, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroğlu, Abdulkadir Baştürk, Tuba Hacıbekiroğlu, Mehmet Hilmi Doğu, İlhami Berber, Kürşat Dal, Mehmet Ali Erkurt, Burhan Turgut, Osman Çelik, Mustafa Mahir Ülgü, Şuayıp Birinci, Turkish Ministry of Health, Hematology Scientific Working Group
Topics & Concepts
MedicineInternal medicineCancerCase fatality rateIntensive care unitHematologyCoronavirus disease 2019 (COVID-19)Hematologic NeoplasmsPopulationHematologic diseaseDiseaseEpidemiologyInfectious disease (medical specialty)Environmental healthCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesHealthcare cost, quality, practices